NO870967L - Hybridinterferoner, deres anvendelse som legemiddel og som mellomprodukter for fremstilling av antistoffer og deres anvendelse samt fremgangsmter ved deres fremstilling. - Google Patents
Hybridinterferoner, deres anvendelse som legemiddel og som mellomprodukter for fremstilling av antistoffer og deres anvendelse samt fremgangsmter ved deres fremstilling.Info
- Publication number
- NO870967L NO870967L NO870967A NO870967A NO870967L NO 870967 L NO870967 L NO 870967L NO 870967 A NO870967 A NO 870967A NO 870967 A NO870967 A NO 870967A NO 870967 L NO870967 L NO 870967L
- Authority
- NO
- Norway
- Prior art keywords
- interferons
- novel
- preparation
- hybrid
- omega
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
- Soft Magnetic Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863607835 DE3607835A1 (de) | 1986-03-10 | 1986-03-10 | Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO870967D0 NO870967D0 (no) | 1987-03-09 |
| NO870967L true NO870967L (no) | 1987-09-11 |
Family
ID=6295926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO870967A NO870967L (no) | 1986-03-10 | 1987-03-09 | Hybridinterferoner, deres anvendelse som legemiddel og som mellomprodukter for fremstilling av antistoffer og deres anvendelse samt fremgangsmter ved deres fremstilling. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4917887A (fi) |
| EP (1) | EP0236920B1 (fi) |
| JP (1) | JPS62282595A (fi) |
| KR (1) | KR950008191B1 (fi) |
| AT (1) | ATE81671T1 (fi) |
| AU (1) | AU600702B2 (fi) |
| DD (2) | DD266118A5 (fi) |
| DE (2) | DE3607835A1 (fi) |
| DK (1) | DK120387A (fi) |
| ES (1) | ES2052502T3 (fi) |
| FI (2) | FI871012A (fi) |
| GR (1) | GR3006844T3 (fi) |
| HU (1) | HU206896B (fi) |
| IE (2) | IE940131L (fi) |
| IL (1) | IL81832A0 (fi) |
| NO (1) | NO870967L (fi) |
| NZ (1) | NZ219549A (fi) |
| PH (1) | PH27060A (fi) |
| PT (1) | PT84427B (fi) |
| SU (1) | SU1604164A3 (fi) |
| ZA (1) | ZA871679B (fi) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3633323A1 (de) * | 1986-10-01 | 1988-04-07 | Boehringer Ingelheim Int | Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega |
| DE3642096A1 (de) * | 1986-12-10 | 1988-06-16 | Boehringer Ingelheim Int | Pferde-(gamma)-interferon |
| AT389318B (de) * | 1987-10-22 | 1989-11-27 | Boehringer Ingelheim Int | Neue hybridomzellinien, welche neue monoklonale antikoerper gegen ifn-omega produzieren, verfahren zu ihrer herstellung und die verwendung der neuen monoklonalen antikoerper zur reinigung sowie zum nachweis von ifn-omega |
| US5015485A (en) * | 1989-05-30 | 1991-05-14 | Nabisco Brands, Inc. | Dog biscuits having a coating containing an inorganic pyrophosphate |
| US5000973A (en) * | 1989-05-30 | 1991-03-19 | Nabisco Brands, Inc. | Nutritionally-balanced canine biscuits containing an inorganic pyrophosphate |
| US5047231A (en) * | 1989-05-30 | 1991-09-10 | Nabisco Brands, Inc. | Raw hide containing an inorganic pyrophosphate |
| US5000940A (en) * | 1989-05-30 | 1991-03-19 | Nabisco Brands, Inc. | Devices, compositions and the like having or containing an inorganic pyrophosphate |
| US5000943A (en) * | 1989-05-30 | 1991-03-19 | Nabisco Brands, Inc. | Canine biscuits containing an inorganic pyrophosphate |
| EP0626448A3 (de) * | 1993-05-26 | 1998-01-14 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Verfahren zur Herstellung und Reinigung von alpha-Interferon |
| US5939286A (en) * | 1995-05-10 | 1999-08-17 | University Of Florida | Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them |
| US6204022B1 (en) | 1996-04-12 | 2001-03-20 | Pepgen Corporation And University Of Florida | Low-toxicity human interferon-alpha analogs |
| EP1987845B1 (en) | 1997-11-20 | 2012-03-21 | Vical Incorporated | Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor. |
| AU770018B2 (en) * | 1998-03-13 | 2004-02-12 | Brown University Research Foundation | Human N-type calcium channel isoform and uses thereof |
| US6685933B1 (en) | 1998-07-28 | 2004-02-03 | The United States Of America As Represented By The Department Of Health And Human Services | Interferon α hybrids |
| CN100420482C (zh) * | 2000-11-03 | 2008-09-24 | 精达制药公司 | ω干扰素在制备用于治疗丙型肝炎的药物中的用途 |
| FR2821625B1 (fr) * | 2001-03-01 | 2003-05-16 | Genodyssee | Nouveaux polynucleotides comportant un polymorphisme de type snp fonctionnel dans la sequence nucleotidique du gene ifn-alpha-2 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques |
| FR2823220B1 (fr) | 2001-04-04 | 2003-12-12 | Genodyssee | Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo) |
| WO2003016472A2 (en) * | 2001-08-12 | 2003-02-27 | Pepgen Corporation | Hybrid interferon/interferon tau proteins, compositions and methods of use |
| WO2004099231A2 (en) | 2003-04-09 | 2004-11-18 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| KR20040053291A (ko) * | 2001-11-09 | 2004-06-23 | 바이오메디신즈 인코포레이티드 | 오메가 인터페론을 이용한 질환 치료 방법 |
| US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| CA2651855C (en) | 2006-05-30 | 2011-08-02 | Intarcia Therapeutics, Inc. | Two-piece, internal-channel osmotic delivery system flow modulator |
| ES2422864T3 (es) | 2006-08-09 | 2013-09-16 | Intarcia Therapeutics, Inc | Sistemas de liberación osmótica y unidades de pistón |
| PT2157967E (pt) | 2007-04-23 | 2013-04-03 | Intarcia Therapeutics Inc | Formulações de suspensões de péptidos insulinotrópicos e suas utilizações |
| EP2240155B1 (en) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Devices, formulations, and methods for delivery of multiple beneficial agents |
| KR101823699B1 (ko) | 2009-09-28 | 2018-01-30 | 인타르시아 세라퓨틱스 인코포레이티드 | 실질 항정상태 약물 전달의 신속 확립 및/또는 종결 |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| JP6466904B2 (ja) * | 2013-03-15 | 2019-02-06 | ヤンセン バイオテツク，インコーポレーテツド | インターフェロンアルファ及びオメガ抗体アンタゴニスト |
| TWI713453B (zh) * | 2014-06-23 | 2020-12-21 | 美商健生生物科技公司 | 干擾素α及ω抗體拮抗劑 |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| US10925639B2 (en) | 2015-06-03 | 2021-02-23 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
| KR102574993B1 (ko) | 2016-05-16 | 2023-09-06 | 인타르시아 세라퓨틱스 인코포레이티드 | 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법 |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| KR20190104039A (ko) | 2017-01-03 | 2019-09-05 | 인타르시아 세라퓨틱스 인코포레이티드 | Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI77877C (fi) * | 1979-04-20 | 1989-05-10 | Technobiotic Ltd | Foerfarande foer framstaellning och rening av human le-formig interferonprotein. |
| ES8302778A1 (es) * | 1980-11-10 | 1983-02-01 | Genentech Inc | Un procedimiento para producir un polipeptido antiviral. |
| US4456748A (en) * | 1981-02-23 | 1984-06-26 | Genentech, Inc. | Hybrid human leukocyte interferons |
| JPH064673B2 (ja) * | 1980-11-10 | 1994-01-19 | ゲネンテツク・インコ−ポレ−テツド | ハイブリド型ヒト白血球インタフエロン |
| US4414150A (en) * | 1980-11-10 | 1983-11-08 | Genentech, Inc. | Hybrid human leukocyte interferons |
| WO1983002461A1 (en) * | 1982-01-19 | 1983-07-21 | Cetus Corp | Multiclass hybrid interferons |
| AU1155083A (en) * | 1982-01-19 | 1983-07-28 | Cetus Corporation | Multiclass hybrid interferons |
| DE3247922A1 (de) * | 1982-12-24 | 1984-06-28 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten |
| DE3409966A1 (de) * | 1984-03-19 | 1985-09-26 | Hoechst Ag, 6230 Frankfurt | Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens |
| DE3428370A1 (de) * | 1984-08-01 | 1986-02-13 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Interferon, genetische sequenzen, die hierfuer codieren, und diese produzierende organismen |
| DE3584198D1 (de) * | 1984-08-01 | 1991-10-31 | Boehringer Ingelheim Int | Neue genetische sequenzen, die durch sie codierten interferon-peptide vom typ i und diese sie produzierende organismen. |
| DE3574145D1 (en) * | 1984-08-27 | 1989-12-14 | Genentech Inc | Novel, distinct family of human leukocyte interferons, compositions containing them, methods for their production, and dna and transfected hosts therefor |
| EP0173935A1 (en) * | 1984-08-31 | 1986-03-12 | University Patents, Inc. | Hybrid lymphoblastoid-leukocyte human interferons |
| DE3685996T2 (de) * | 1985-06-11 | 1993-01-14 | Ciba Geigy Ag | Hybrid-interferone. |
| US4935233A (en) * | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
-
1986
- 1986-03-10 DE DE19863607835 patent/DE3607835A1/de not_active Withdrawn
-
1987
- 1987-03-04 EP EP87103030A patent/EP0236920B1/de not_active Expired - Lifetime
- 1987-03-04 DE DE8787103030T patent/DE3782259D1/de not_active Expired - Fee Related
- 1987-03-04 ES ES87103030T patent/ES2052502T3/es not_active Expired - Lifetime
- 1987-03-04 AT AT87103030T patent/ATE81671T1/de not_active IP Right Cessation
- 1987-03-06 AU AU69786/87A patent/AU600702B2/en not_active Ceased
- 1987-03-09 SU SU874202086A patent/SU1604164A3/ru active
- 1987-03-09 FI FI871012A patent/FI871012A/fi not_active Application Discontinuation
- 1987-03-09 IL IL81832A patent/IL81832A0/xx not_active IP Right Cessation
- 1987-03-09 DD DD87300598A patent/DD266118A5/de not_active IP Right Cessation
- 1987-03-09 US US07/023,634 patent/US4917887A/en not_active Expired - Fee Related
- 1987-03-09 IE IE940131A patent/IE940131L/xx unknown
- 1987-03-09 ZA ZA871679A patent/ZA871679B/xx unknown
- 1987-03-09 NO NO870967A patent/NO870967L/no unknown
- 1987-03-09 HU HU87995A patent/HU206896B/hu unknown
- 1987-03-09 DD DD32350187A patent/DD276493A5/de not_active IP Right Cessation
- 1987-03-09 JP JP62053911A patent/JPS62282595A/ja active Pending
- 1987-03-09 NZ NZ219549A patent/NZ219549A/xx unknown
- 1987-03-09 DK DK120387A patent/DK120387A/da not_active Application Discontinuation
- 1987-03-09 IE IE59187A patent/IE60573B1/en not_active IP Right Cessation
- 1987-03-09 PT PT84427A patent/PT84427B/pt not_active IP Right Cessation
- 1987-03-10 PH PH34995A patent/PH27060A/en unknown
- 1987-03-10 KR KR1019870002106A patent/KR950008191B1/ko active IP Right Grant
-
1992
- 1992-12-11 FI FI925631A patent/FI925631A/fi not_active Application Discontinuation
-
1993
- 1993-01-21 GR GR930400095T patent/GR3006844T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE81671T1 (de) | 1992-11-15 |
| IE940131L (en) | 1987-09-10 |
| PH27060A (en) | 1993-02-01 |
| FI925631A0 (fi) | 1992-12-11 |
| PT84427A (de) | 1987-04-01 |
| SU1604164A3 (ru) | 1990-10-30 |
| HUT44074A (en) | 1988-01-28 |
| DK120387A (da) | 1987-09-11 |
| DE3607835A1 (de) | 1987-09-24 |
| EP0236920A2 (de) | 1987-09-16 |
| DE3782259D1 (de) | 1992-11-26 |
| NZ219549A (en) | 1990-07-26 |
| KR870009020A (ko) | 1987-10-22 |
| DK120387D0 (da) | 1987-03-09 |
| KR950008191B1 (ko) | 1995-07-26 |
| ES2052502T3 (es) | 1994-07-16 |
| DD276493A5 (de) | 1990-02-28 |
| NO870967D0 (no) | 1987-03-09 |
| EP0236920B1 (de) | 1992-10-21 |
| FI925631A (fi) | 1992-12-11 |
| FI871012A0 (fi) | 1987-03-09 |
| IE60573B1 (en) | 1994-07-27 |
| DD266118A5 (de) | 1989-03-22 |
| EP0236920A3 (en) | 1988-03-02 |
| US4917887A (en) | 1990-04-17 |
| PT84427B (pt) | 1989-10-04 |
| HU206896B (en) | 1993-01-28 |
| GR3006844T3 (fi) | 1993-06-30 |
| JPS62282595A (ja) | 1987-12-08 |
| ZA871679B (en) | 1988-11-30 |
| AU6978687A (en) | 1987-09-17 |
| AU600702B2 (en) | 1990-08-23 |
| IE870591L (en) | 1987-09-10 |
| IL81832A0 (en) | 1987-10-20 |
| FI871012A (fi) | 1987-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO870967L (no) | Hybridinterferoner, deres anvendelse som legemiddel og som mellomprodukter for fremstilling av antistoffer og deres anvendelse samt fremgangsmter ved deres fremstilling. | |
| NO831317L (no) | Fremgangsmaate for fremstilling av funksjonelle menneske-urokinase proteiner. | |
| BR1101088A (pt) | Proteìna g do vìrus sincicial respiratório não glicosilada isolada e substancialmente pura | |
| DE69428214D1 (de) | Transformierender wachstumsfaktor alpha h1 | |
| FI864427A0 (fi) | Menetelmä polypeptidin valmistamiseksi, joka on komplementaarinen ainakin osalle alkuperäistä peptidiä tai proteiinia, ja komplementaarisen polypeptidin käyttö | |
| IL72985A0 (en) | Homogenous immune interferon fragment,its manufacture and pharmaceutical compositions containing it | |
| DE68925226D1 (de) | Monoklonale Antikörper | |
| IL80562A0 (en) | Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it | |
| FI953525A (fi) | Kemiallinen syntetointimenetelmä fibronektiiniä sitovan proteiinin tai polypeptidin valmistamiseksi | |
| GR3007031T3 (fi) | ||
| FI882891A (fi) | Menetelmä angiogeenisen tekijän tuottamiseksi | |
| IL82720A0 (en) | Recombinant polypeptide containing the amino acid sequence of the protein of feline leukemia virus,expression vehicles,plasmids coding for said protein,method for production thereof and pharmaceutical compositions |